Sex steroids have a significant effect on skeletal biology in men, with reduced levels being associ ated with lower skeletal bone mass and cortical thickness. The purpose of this study was to deter mine if sex steroids are associated with periodon titis and tooth loss in a cohort of 1210 older dentate men followed for 3 years. Periodontal measures included attachment loss, pocket depth, gingival bleeding, and number of teeth. Baseline serum testosterone and estradiol were measured by radioimmunoassay. Severe periodontitis was common at baseline (38%), and progression occurred in 32% of the cohort. Incident tooth loss occurred in 22% of the cohort. Testosterone, estra diol, and sex hormone binding globulin (SHBG) concentrations were not related to baseline perio dontal status or number of teeth. Moreover, there was no relationship between sex steroid levels and periodontitis progression or incident tooth loss. Although periodontitis, progression of periodontitis, and tooth loss are common in older men, they were not associated with sex steroids.
MATERIALS & METHOdS
The Osteoporotic Fractures in Men (MrOS) Study is a prospective, observa tional study of a cohort of communitydwelling ambulatory men > 65 yrs old. During 20002002, MrOS recruited 5995 older men at six clinical sites. All participants completed a questionnaire concerning demographic characteris tics, medical history, tobacco and alcohol use, and lifestyle. Participants also took part in a baseline visit that included measures of height and weight and col lection of morning fasting blood. Information on MrOS recruitment strategies and study design has been published elsewhere Orwoll et al., 2005) . In 20022003, study participants at two of the clinical sites were enrolled in the MrOS Dental Study. Men who completed the first MrOS Dental Study visit (Visit 1) were invited to a second visit (Visit 2) in 20052006, an average of 2.7 yrs after Visit 1 (SD = 0.2, range = 1.93.5). This study was approved by the Institutional Review Boards at Oregon Health & Science University and the University of Alabama at Birmingham; informed consent was obtained from all study participants.
Periodontal Assessment
All examinations were completed by calibrated dentists and hygienists. Missing teeth and implants were recorded for the full mouth, while the periodontal examination was limited to a random halfmouth. Clinical attachment loss (CAL) and pocket depth (PD) were measured at 6 sites per tooth, as previously described (Phipps et al., 2007) .
We used the periodontitis and periodontitis progression case definitions proposed by the European Workshop in Periodontology (Tonetti et al., 2005) , with one modification to account for our halfmouth design. Our criterion for a periodontitis case was the presence of proximal attachment loss of > 5 mm in at least 30% of teeth examined, rather than teeth present, while the criterion for periodontitis progression was the presence of 2 or more teeth demonstrating a longitudinal loss of proximal attachment of > 3 mm. Since we examined only a halfmouth in each partici pant, it is likely that we underestimated the prevalence and progression of periodontitis.
Incident Tooth Loss
If a participant lost a tooth between Visits 1 and 2, his dentist was contacted to collect information on date of and reason for extraction. Of the 371 men with at least 1 lost tooth, reason for extraction was obtained for 261 (69.6%).
Sex Steroid Measures
Morning serum samples were obtained for sex steroid measures. Total serum estradiol and testosterone levels and sex hormone bind ing globulin (SHBG) concentrations were measured by radioim munoassay, and free estradiol and testosterone levels were calculated, as previously described in detail (Orwoll et al., 2006) .
Statistical Analyses
Bivariate statistical comparisons were made with chisquare tests, t tests, or Pearson correlation coefficients. Linear and logistic regression models were used to estimate the relationship between sex steroid levels and periodontal measures adjusted for study site, examiner nested within study site, age at Visit 1, nonwhite race, college education, body mass index (BMI), diabetes, fair/poor/very poor selfreported general health status, and a history of 20 or more packyears of smoking. Individual models were developed for total testosterone, total estradiol, SHBG, free testosterone, and free estradiol. As a further control for smoking, similar analyses were generated for neversmokers and current nonsmokers. Given that 1019 men completed the followup visit, this study had 80% power to detect an R 2 of 0.007 attributed to each sex steroid variable, and an odds ratio of 0.80 per standard deviation increase in each sex steroid.
We assessed interexaminer reliability for the periodontal examination on a subset of 56 participants who had a second periodontal examination administered by the study's periodontist. Nested models were used to summarize the percentage of total variability explained by the examiner. The interexaminer correlation was 0.79 for CAL and 0.78 for PD. To account for interexaminer error, all statistical models using periodontal examination data include 'examiner nested within site' as a covariate. For change and progression measures, the examiners at both the first and followup visits were included in models.
RESULTS

Participant Characteristics
The 1210 dentate men examined at Visit 1 ranged in age from 6695 yrs, with a mean of 74.6 yrs. The mean number of teeth present was 22.5 (range, 128). The mean gingival index was 1.2 + 0.5, and the prevalence of gingival bleeding was 53%. Mean CAL was 3.0 + 0.8 mm; 82% had at least one site with CAL > 5 mm. The mean PD was 2.5 + 0.5 mm; 85% had at least one site with a PD > 4 mm, while 34% had at least one site with PD > 6 mm. Severe periodontitis was evident in 38% of the men.
Eightyfour percent (n = 1019) of the dentate men who com pleted Visit 1 attended Visit 2. Reasons for not attending Visit 2 included death (n = 76) and refusal (n = 115). The men who did not attend Visit 2 were older, less likely to have attended college, and had higher mean packyears of smoking (Table 1) . Of those who did not attend, 48% had periodontitis at baseline compared with 36% of those who did attend Visit 2 (Table 1) . During followup, 9% of men with baseline periodontitis died compared with 5% without periodontitis (p = 0.02).
Sex Steroid Levels
Sex steroid and SHBG levels were similar to those reported in other cohorts of older men (Ferrini and BarrettConnor, 1998; Travison et al., 2007) . Increasing age was associated with slightly lower total and free testosterone levels (r = -0.1, p = 0.0002 and r = -0.2, p < 0.0001, respectively), lower total and free estradiol levels (r = -0.1, p = 0.0002 and r = -0.17, p < 0.0001, respectively), and higher SHBG levels (r = 0.17, p < 0.0001). Current smokers had higher SHBG levels (60.8 vs. 48.8, p = 0.02), and participants who rated their health as fair/ poor had lower total testosterone (12.1 vs. 13.2 nmol/L, p = 0.02) and free testosterone (0.24 vs. 0.26 nmol/L, p = 0.03) levels than did those with excellent/good health status. Those with fair/poor health had similar levels of total (62.0 vs. 62.3 pmol/L, p = 0.9) and free estradiol (1.63 vs. 1.61 pmol/L, p = 0.8).
Sex Steroids and Periodontal Health at baseline
In analyses adjusted for relevant covariates, sex steroid and SHBG levels were not associated with mean CAL, mean PD, or gingival bleeding (Appendix Table 1 , Appendix Figs. 1, 2) . Although men with severe periodontitis were slightly older, were more often nonwhite, and were more likely to smoke, the levels of sex steroids were not different in men with and without severe periodontitis (Appendix Table 2 ). After adjusting for covariates, we found no significant difference in the proportions of men with severe periodontitis among participants with low testosterone (testosterone < 8.7 nmol/L) vs. higher testosterone levels (43% vs. 37%, p = 0.13). Sex steroid levels were not associated with periodontal measures in models containing total estradiol, total testosterone, and SHBG simultaneously with covariates (data not shown). In addition, we found no significant association (p < 0.01) between periodontal health and sex ste roids when the analyses were restricted to neversmokers or current nonsmokers (data not shown).
We examined whether sex steroid levels were lower in eden tulous men at Visit 1 (n = 136) to assess whether men with low levels had early tooth loss. We found no significant differences in mean total or free testosterone or estradiol between edentu lous and dentate men (data not shown).
Sex Steroids and Progression of Periodontitis
There was progression of periodontal disease in 32% of men. Periodontal progression differed significantly by site (Portland, 19%; Birmingham, 46%) and by examiner. In multivariable analyses, there was no association between progression of periodontitis and sex steroid or SHBG levels measured at Visit 1 after adjustment for covariates including site and examiner (Table 2) . Similarly, there was no association between sex steroid levels and the rate of change in CAL (Table 2) .
Tooth Loss
Eightyfive percent of participants were missing at least 1 tooth at baseline, and additional tooth loss occurred in 22% of men during followup. Periodontitis was cited as the cause of extraction in 16%. There was no association between sex steroid levels and number of teeth at baseline, and multivariate analyses with incident tooth loss as the dependent variable found that sex steroids were not independently associated with tooth loss (Table 3) .
dISCUSSION
In a large population of communitydwelling older men, perio dontitis was common, as were progression of periodontal dis ease and tooth loss. However, sex steroid and SHBG levels were not associated with baseline periodontal measures, worsening of periodontal disease, history of tooth loss, or incident tooth loss.
The study had considerable power to detect associations, and it is unlikely that meaningful relationships were not detected. These findings strongly suggest that sex steroid levels do not influence periodontal health in older men.
Although there are few data available concerning this issue, our findings are somewhat surprising. Testosterone and estradiol levels decline in men with aging, and many of the common sequelae of aging, including loss of bone density and the appear ance of frailty, have been linked to a relative deficiency of sex hormone action (Matsumoto, 2002) . For example, in the overall MrOS study, low levels of estradiol and testosterone were asso ciated with reduced bone mineral density (Mellström et al., 2006) and loss of bone density (Fink et al., 2006) . Moreover, MrOS men with lower sex steroid levels were at increased risk of fracture (Mellström et al., 2006 (Mellström et al., , 2008 . Attention has been drawn to the possible relationships among periodontal disease, oral bone loss, and postmenopausal osteoporosis (Krall, 2001; Jeffcoat, 2005) . Estrogen inhibits the expression of inflammatory cytokines important in bone resorption, and estrogen deficiency may contribute to more intense gingival inflammation during periodontitis and subsequent oral bone loss, and may result in bone loss at both oral and skeletal sites (Lerner, 2006) . Several studies have suggested that the risk of postmenopausal tooth loss is reduced by estrogen replacement (Lerner, 2006) . Further more, lower estrogen levels have been linked to gingival inflam mation (Norderyd et al., 1993) and reduced clinical attachment levels (Reinhardt et al., 1999) . Nevertheless, in this population of older men, we found no relationship between estrogen levels and periodontitis or tooth loss. The reasons for this find ing and the previous associations between oral health and estro gen in older women are not clear. One possibility is that older men have considerably higher levels of estrogen than do post menopausal women, and there may be a threshold estrogen concentration needed for the prevention of oral bone loss. In fact, it has been suggested that there is a threshold level of estradiol in older men above which there is protection against skeletal bone loss (Khosla et al., 2002) .
Testosterone also has a positive effect on bone in men (Wiren and Orwoll, 1999; Vanderschueren et al., 2004) , but the relationships between testosterone levels and oral health have rarely been studied (Daltaban et al., 2006) . Our findings provide no support for a relationship between serum testosterone and perio dontal or oral bone health.
This study had considerable strengths. The MrOS Dental population was large, and was studied with carefully controlled dental measures. Sex steroid measurements were similarly care fully performed, and there was a wide range of concentrations of testosterone and estradiol present in the cohort. Assessments of multiple potential covariates were available. There were also several potential limitations. The men studied were volunteers, and their general health and socioeconomic status were gener ally good. Thus, these results may not be representative of the whole population of older men. Moreover, there were different rates of progression of periodontitis in Portland and Birmingham. This difference may reflect real geographical variation in the nature of periodontitis, but, despite careful crosstraining and calibration, it also may represent site differences in measurement techniques. Nevertheless, periodontitis was common at baseline, and progression of disease occurred in many participants at both clinic sites. It is highly likely that a meaningful effect of sex steroids on the course of periodontal disease would have been detected. The population studied was primarily Caucasian, and these results may not be generalizable to other racial groups. Whereas we found no associations between sex steroid levels and periodontal status, this cannot be taken as evidence that sex steroid supplementation would have no effect.
In summary, this is the first large study of the associations between periodontal disease and sex steroid levels in men. We found no evidence that serum sex steroid concentrations were associated with measures of periodontal disease, subsequent progression of disease, the number of teeth at baseline, or inci dent tooth loss. Linear regression and logistic models adjusted for clinic site, age, nonwhite race, college education or higher, BMI, diabetes, fair/poor/ very poor general health, 20+ pack-years of smoking.
